ReviewProblemy endokrinologii2026

[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof].

N I Cheplyaeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.